Quidel® Lyra Direct C. difficile Assay
for qualitative and direct detection

The Quidel® Lyra™ Direct C. difficile Assay is a qualitative, multiplexed in vitro diagnostic test for the direct detection of toxin A gene (tcdA) or toxin B gene (tcdB) sequences of toxigenic strains of Clostridium difficile from unformed (liquid or soft) stool specimens collected from patients suspected of having Clostridium difficile-Associated Disease (CDAD).

Benefits of Quidel® Lyra Direct C. difficile Assay Kits

CE-IVD and IVD labeled
Helps achieve 99% sensitivity and 99% specificity
No sample prep required (just two dilutions)
Product information
Ordering information
Product Quantity Cat. No.
Quidel® Lyra™ Direct C. difficile Assay
(For sale in the US and Europe only. The assay is validated for use on the QuantStudio® Dx and Applied Biosystems® 7500 Fast Dx Real-Time Instruments.)
96 reactions 4476855
Quidel® Lyra™ Direct C. difficile External Controls 10 reactions 4477230

Videos & Webinars

Antibiotic-Resistance-Report-Pod